Australia and New Zealand Diagnostic Imaging Services Market Report and Forecast 2024-2032
Australia and New Zealand Diagnostic Imaging Services Market Report and Forecast 2024-2032
Australia and New Zealand Diagnostic Imaging Services Market Outlook
The Australia and New Zealand diagnostic imaging services market size is anticipated to grow at a CAGR of 6.34% during the forecast period of 2024-2032, driven by the increased advancements in imaging technology.
Diagnostic Imaging Services: Introduction
Imaging services are a cornerstone of modern healthcare, providing detailed visual representations of the body's interior for diagnostic and treatment purposes. These services encompass a range of techniques such as X-rays, MRI (Magnetic Resonance Imaging), CT (Computed Tomography) scans, ultrasound, and PET (Positron Emission Tomography). They are pivotal in early disease detection, monitoring treatment progress, and guiding surgical procedures, thereby playing a crucial role in patient care and medical decision-making.
Key Trends in the Australia and New Zealand Diagnostic Imaging Services Market
Continuous advancements in imaging technology, including enhanced image quality, faster processing times, and reduced radiation exposure, are driving market growth.
Artificial intelligence is increasingly used in imaging services for improved diagnostic accuracy, predictive analytics, and workflow efficiency. A shift towards portable imaging devices, facilitating point-of-care diagnostics and making imaging services more accessible, especially in remote areas.
Expansion of tele-radiology, allowing remote interpretation of medical images by experts, thus improving access to specialized care and reducing diagnosis times. Imaging services are becoming more patient-centric, with personalized imaging protocols based on individual health profiles and genetic information.
Adoption of hybrid imaging technologies, like PET/CT and SPECT/CT, offering combined functionalities for more comprehensive diagnostics. Emphasis on Preventative Care: Growing emphasis on early disease detection and preventative care, increasing the demand for regular and advanced imaging services.
Australia and New Zealand Diagnostic Imaging Services Market Segmentation
Market Breakup by Modality
- MRI
- Computed Tomography
- Ultrasound
- X-ray
- Nuclear Imaging
- Fluoroscopy
- Mammography
- Other Modalities
- Cardiology
- Oncology
- Neurology
- Orthopedics
- Gastroenterology
- Gynecology
- Other Applications
- Hospitals
- Imaging Centres
- Research Centres
- Australia
- New Zealand
In Australia, the imaging services market is characterized by advanced healthcare infrastructure and a strong focus on innovation. Collaborations between public healthcare systems and private imaging service providers to expand access and improve service efficiency. Rapid adoption of state-of-the-art imaging technologies, like AI-enhanced interpretation and 3D imaging, to improve diagnostic accuracy and patient outcomes. An increasing elderly population necessitates more imaging services for chronic conditions and age-related diseases. Development of remote imaging services and tele-radiology to serve Australia's vast and sparsely populated areas, ensuring wider healthcare coverage.
In New Zealand, the imaging services market trends reflect a commitment to high-quality healthcare and equitable access. Emphasis on ensuring equitable access to imaging services across both urban and remote areas, aligning with the country's healthcare policies. Efforts to integrate imaging services more closely with other healthcare services, facilitating comprehensive patient care. An adoption of eco-friendly practices in imaging centers, reducing the environmental impact of healthcare services. A strong adherence to national and international standards in imaging services to ensure high-quality, safe, and reliable patient care.
Australia and New Zealand Diagnostic Imaging Services Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
- Siemens Healthineers
- GE Healthcare
- Philips Healthcare
- Fujifilm Holdings Corporation
- Hologic, Inc.
- Hitachi Medical Corporation
- Shimadzu Corporation
- Carestream Health, Inc.
- Canon Medical Systems Corporation
- Toshiba Medical Systems Corporation (now part of Canon Medical Systems)
- Agfa-Gevaert Group
- Samsung Medison Co., Ltd.
- Aurora Imaging Technology, Inc.
- Esaote S.p.A.
- Mindray Medical International Limited
*Please Note:* The report will take 7 business days to complete, after order confirmation.
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Australia and New Zealand Diagnostic Imaging Services Market Overview
- 3.1 Australia and New Zealand Diagnostic Imaging Services Market Historical Value (2017-2023)
- 3.2 Australia and New Zealand Diagnostic Imaging Services Market Forecast Value (2024-2032)
- 4 Australia and New Zealand Diagnostic Imaging Services Market Dynamics
- 4.1 Market Drivers and Constraints
- 4.2 SWOT Analysis
- 4.3 Porter’s Five Forces Model
- 4.4 Key Demand Indicators
- 4.5 Key Price Indicators
- 4.6 Industry Events, Initiatives, and Trends
- 4.7 Value Chain Analysis
- 5 Australia and New Zealand Diagnostic Imaging Services Market Segmentation
- 5.1 Australia and New Zealand Diagnostic Imaging Services Market by Modality
- 5.1.1 MRI
- 5.1.2 Computed Tomography
- 5.1.3 Ultrasound
- 5.1.4 X-ray
- 5.1.5 Nuclear Imaging
- 5.1.6 Fluoroscopy
- 5.1.7 Mammography
- 5.1.8 Other Modalities
- 5.2 Australia and New Zealand Diagnostic Imaging Services Market by Application
- 5.2.1 Market Overview
- 5.2.2 Cardiology
- 5.2.3 Oncology
- 5.2.4 Neurology
- 5.2.5 Orthopedics
- 5.2.6 Gastroenterology
- 5.2.7 Gynecology
- 5.2.8 Other Applications
- 5.3 Australia and New Zealand Diagnostic Imaging Services Market by End User
- 5.3.1 Market Overview
- 5.3.2 Hospitals
- 5.3.3 Diagnostic Centres
- 5.3.4 Others
- 5.4 Australia and New Zealand Diagnostic Imaging Services Market by Country
- 5.4.1 Market Overview
- 5.4.2 Australia
- 5.4.3 New Zealand
- 6 Patent Analysis
- 6.1 Analysis by Type of Patent
- 6.2 Analysis by Publication year
- 6.3 Analysis by Issuing Authority
- 6.4 Analysis by Patent Age
- 6.5 Analysis by CPC Analysis
- 6.6 Analysis by Patent Valuation
- 6.7 Analysis by Key Players
- 7 Grants Analysis
- 7.1 Analysis by year
- 7.2 Analysis by Amount Awarded
- 7.3 Analysis by Issuing Authority
- 7.4 Analysis by Grant Application
- 7.5 Analysis by Funding Institute
- 7.6 Analysis by NIH Departments
- 7.7 Analysis by Recipient Organization
- 8 Funding Analysis
- 8.1 Analysis by Funding Instances
- 8.2 Analysis by Type of Funding
- 8.3 Analysis by Funding Amount
- 8.4 Analysis by Leading Players
- 8.5 Analysis by Leading Investors
- 8.6 Analysis by Geography
- 9 Partnership and Collaborations Analysis
- 9.1 Analysis by Partnership Instances
- 9.2 Analysis by Type of Partnership
- 9.3 Analysis by Leading Players
- 9.4 Analysis by Geography
- 10 Regulatory Framework
- 10.1 Regulatory Overview
- 11 Supplier Landscape
- 11.1 Siemens Healthineers
- 11.1.1 Financial Analysis
- 11.1.2 Product Portfolio
- 11.1.3 Demographic Reach and Achievements
- 11.1.4 Mergers and Acquisitions
- 11.1.5 Certifications
- 11.2 GE Healthcare
- 11.2.1 Financial Analysis
- 11.2.2 Product Portfolio
- 11.2.3 Demographic Reach and Achievements
- 11.2.4 Mergers and Acquisitions
- 11.2.5 Certifications
- 11.3 Philips Healthcare
- 11.3.1 Financial Analysis
- 11.3.2 Product Portfolio
- 11.3.3 Demographic Reach and Achievements
- 11.3.4 Mergers and Acquisitions
- 11.3.5 Certifications
- 11.4 Fujifilm Holdings Corporation
- 11.4.1 Financial Analysis
- 11.4.2 Financial Portfolio
- 11.4.3 Demographic Reach and Achievements
- 11.4.4 Mergers and Acquisitions
- 11.4.5 Certifications
- 11.5 Hologic Inc.
- 11.5.1 Financial Analysis
- 11.5.2 Product Portfolio
- 11.5.3 Demographic Reach and Achievements
- 11.5.4 Mergers and Acquisitions
- 11.5.5 Certifications
- 11.6 Hitachi Medical Corporation
- 11.6.1 Financial Analysis
- 11.6.2 Product Portfolio
- 11.6.3 Demographic Reach and Achievements
- 11.6.4 Mergers and Acquisitions
- 11.6.5 Certifications
- 11.7 Shimadzu Corporation
- 11.7.1 Financial Analysis
- 11.7.2 Product Portfolio
- 11.7.3 Demographic Reach and Achievements
- 11.7.4 Mergers and Acquisitions
- 11.7.5 Certifications
- 11.8 Carestream Health, Inc.
- 11.8.1 Financial Analysis
- 11.8.2 Product Portfolio
- 11.8.3 Demographic Reach and Achievements
- 11.8.4 Mergers and Acquisitions
- 11.8.5 Certifications
- 11.9 Canon Medical Systems Corporation
- 11.9.1 Financial Analysis
- 11.9.2 Product Portfolio
- 11.9.3 Demographic Reach and Achievements
- 11.9.4 Mergers and Acquisitions
- 11.9.5 Certifications
- 11.10 Toshiba Medical Systems Corporation (now part of Canon Medical Systems)
- 11.10.1 Financial Analysis
- 11.10.2 Product Portfolio
- 11.10.3 Demographic Reach and Achievements
- 11.10.4 Mergers and Acquisitions
- 11.10.5 Certifications
- 11.11 Agfa-Gevaert Group
- 11.11.1 Financial Analysis
- 11.11.2 Product Portfolio
- 11.11.3 Demographic Reach and Achievements
- 11.11.4 Mergers and Acquisitions
- 11.11.5 Certifications
- 11.12 Samsung Medison Co., Ltd.
- 11.12.1 Financial Analysis
- 11.12.2 Financial Portfolio
- 11.12.3 Demographic Reach and Achievements
- 11.12.4 Mergers and Acquisitions
- 11.12.5 Certifications
- 11.13 Aurora Imaging Technology, Inc.
- 11.13.1 Financial Analysis
- 11.13.2 Product Portfolio
- 11.13.3 Demographic Reach and Achievements
- 11.13.4 Mergers and Acquisitions
- 11.13.5 Certifications
- 11.14 Esaote S.p.A.
- 11.14.1 Financial Analysis
- 11.14.2 Product Portfolio
- 11.14.3 Demographic Reach and Achievements
- 11.14.4 Mergers and Acquisitions
- 11.14.5 Certifications
- 11.15 Mindray Medical International Limited
- 11.15.1 Financial Analysis
- 11.15.2 Product Portfolio
- 11.15.3 Demographic Reach and Achievements
- 11.15.4 Mergers and Acquisitions
- 11.15.5 Certifications
- 12 Australia and New Zealand Diagnostic Imaging Services Market - Distribution Model (Additional Insight)
- 12.1 Overview
- 12.2 Potential Distributors
- 12.3 Key Parameters for Distribution Partner Assessment
- 13 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 14 Company Competitiveness Analysis (Additional Insight)
- 14.1 Very Small Companies
- 14.2 Small Companies
- 14.3 Mid-Sized Companies
- 14.4 Large Companies
- 14.5 Very Large Companies
- 15 Payment Methods (Additional Insight)
- 15.1 Government Funded
- 15.2 Private Insurance
- 15.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook